Document is current
Any future updates will be listed below
-
Authors
Zhu, Zaihua
Xue, Yu
Chu, Tianshu
Hu, Jiankang
Gou, Wei
Zhang, Ning
Li, Juan
Yu, Jing
Li, Rongping
Li, Rongbin
Qian, Long
Duan, Xinwang
Duan, Lihua
Xu, Qian
Gu, Fei
Lian, Yuling
Zhang, Xu
Zou, Hejian https://orcid.org/0000-0001-9762-2663
-
Funding
Funding for this research was provided by:
Changchun GeneScience Pharmaceutical Co., Ltd
- License Information
-
More Information
Article History
Received: 13 February 2026
Accepted: 15 April 2026
First Online: 19 May 2026
Declarations
Conflict of Interest: Qian Xu, Fei Gu, Yuling Lian, and Xu Zhang are employees of Changchun GeneScience Pharmaceutical Co., Ltd. Zaihua Zhu, Yu Xue, Tianshu Chu, Jiankang Hu, Wei Gou, Ning Zhang, Juan Li, Jing Yu, Rongping Li, Rongbin Li, Long Qian, Xinwang Duan, Lihua Duan, and Hejian Zou declare that they have nothing to disclose.
Ethical Approval: This study followed Good Clinical Practice guidelines, and the principles of the Declaration of Helsinki. Ethical approval was obtained from the ethics review committee of Huashan hospital, Fudan University (2022, clinical review No. 976) and the ethical committees at each study site. Each patient provided informed consent before joining the study. The trial was registered at ClinicalTrials.gov ( NCT05983445 ).
